552 related articles for article (PubMed ID: 28615201)
41. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Renne R; Barry C; Dittmer D; Compitello N; Brown PO; Ganem D
J Virol; 2001 Jan; 75(1):458-68. PubMed ID: 11119614
[TBL] [Abstract][Full Text] [Related]
42. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter.
Cloutier N; Flamand L
J Biol Chem; 2010 Mar; 285(10):7208-21. PubMed ID: 20048166
[TBL] [Abstract][Full Text] [Related]
43. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Garber AC; Shu MA; Hu J; Renne R
J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733
[TBL] [Abstract][Full Text] [Related]
44. KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription.
Gupta N; Thakker S; Verma SC
Sci Rep; 2016 Sep; 6():32633. PubMed ID: 27599637
[TBL] [Abstract][Full Text] [Related]
45. Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency.
Ohsaki E; Suzuki T; Karayama M; Ueda K
Virus Res; 2009 Jan; 139(1):74-84. PubMed ID: 19027806
[TBL] [Abstract][Full Text] [Related]
46. Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Jeong JH; Orvis J; Kim JW; McMurtrey CP; Renne R; Dittmer DP
J Biol Chem; 2004 Apr; 279(16):16822-31. PubMed ID: 14742422
[TBL] [Abstract][Full Text] [Related]
47. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
Skalsky RL; Hu J; Renne R
J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
[TBL] [Abstract][Full Text] [Related]
48. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions.
Cai Q; Lan K; Verma SC; Si H; Lin D; Robertson ES
J Virol; 2006 Aug; 80(16):7965-75. PubMed ID: 16873253
[TBL] [Abstract][Full Text] [Related]
49. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.
Jeong JH; Hines-Boykin R; Ash JD; Dittmer DP
J Virol; 2002 Nov; 76(21):11024-32. PubMed ID: 12368345
[TBL] [Abstract][Full Text] [Related]
50. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
[TBL] [Abstract][Full Text] [Related]
51. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors.
Veeranna RP; Haque M; Davis DA; Yang M; Yarchoan R
J Virol; 2012 Jan; 86(2):1097-108. PubMed ID: 22090111
[TBL] [Abstract][Full Text] [Related]
52. Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region.
Su L; Liao Q; Wu Y; Chen X
PLoS One; 2011 Apr; 6(4):e19106. PubMed ID: 21544244
[TBL] [Abstract][Full Text] [Related]
53. Proteomic profiling identifies the SIM-associated complex of KSHV-encoded LANA.
Gan J; Wang C; Jin Y; Guo Y; Xu F; Zhu Q; Ding L; Shang H; Wang J; Wei F; Cai Q; Robertson ES
Proteomics; 2015 Jun; 15(12):2023-37. PubMed ID: 25894481
[TBL] [Abstract][Full Text] [Related]
54. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
Sun Z; Jha HC; Robertson ES
J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
[TBL] [Abstract][Full Text] [Related]
55. LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex.
Hu J; Yang Y; Turner PC; Jain V; McIntyre LM; Renne R
PLoS Pathog; 2014 Jul; 10(7):e1004240. PubMed ID: 25033463
[TBL] [Abstract][Full Text] [Related]
56. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
[TBL] [Abstract][Full Text] [Related]
57. KSHV LANA--the master regulator of KSHV latency.
Uppal T; Banerjee S; Sun Z; Verma SC; Robertson ES
Viruses; 2014 Dec; 6(12):4961-98. PubMed ID: 25514370
[TBL] [Abstract][Full Text] [Related]
58. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
59. Minichromosome Maintenance Proteins Cooperate with LANA during the G
Dabral P; Uppal T; Rossetto CC; Verma SC
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651368
[TBL] [Abstract][Full Text] [Related]
60. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
